WEINBERG URI (Chief Science Officer) sold 4.6% of their position (10.73K shares) of NOVOCURE LTD on the open market
Open‑market sale worth $146.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/3/2026ACC: 0001811030-26-000002
Officer· Chief Science Officer
Since Apr 2020
+2.26K
Net shares
Net buyer
$146.9K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
12.99K acquired · 10.73K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−7.46K
Price / share
$13.84
Trade value
$103.26K
% of position
3.4%
2/27/2026
221.22K→213.76K
Ordinary Shares
Direct
Shares
+12.99K
Price / share
—
Trade value
—
% of position
6.1%
2/28/2026
213.76K→226.75K
Ordinary Shares
Direct
Shares
−3.27K
Price / share
$13.33
Trade value
$43.61K
% of position
1.4%
3/2/2026
226.75K→223.48K
Total
Net shares
+2.26K
Net value
-$146.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/27/2026 | S · Sale | −7.46K | $13.84 | $103.26K | 3.4% | 221.22K | 213.76K |
| Ordinary Shares Direct | 2/28/2026 | A · Award | +12.99K | — | — | 6.1% | 213.76K | 226.75K |
| Ordinary Shares Direct | 3/2/2026 | S · Sale | −3.27K | $13.33 | $43.61K | 1.4% | 226.75K | 223.48K |
| Total | +2.26K | -$146.86K | ||||||
Derivative Transactions0
No derivative transactions reported